{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:48:36Z","timestamp":1792619316917,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"vor","delay-in-days":2527,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1074\/jbc.m113.472563","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T11:02:45Z","timestamp":1381489365000},"page":"34181-34189","source":"Crossref","is-referenced-by-count":50,"title":["The Antiparasitic Clioquinol Induces Apoptosis in Leukemia and Myeloma Cells by Inhibiting Histone Deacetylase Activity"],"prefix":"10.1016","volume":"288","author":[{"given":"Biyin","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunkun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aining","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.472563_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nm.2305","article-title":"Cancer epigenetics reaches mainstream oncology","volume":"17","author":"Rodr\u00edguez-Paredes","year":"2011","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M113.472563_bib2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1074\/jbc.M113.472563_bib3","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","article-title":"HATs and HDACs. From structure, function and regulation to novel strategies for therapy and prevention","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.472563_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription. From molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res"},{"key":"10.1074\/jbc.M113.472563_bib5","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1158\/0008-5472.CAN-09-3028","article-title":"Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage","volume":"70","author":"Conti","year":"2010","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M113.472563_bib6","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"27","author":"Lane","year":"2009","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/jbc.M113.472563_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bjp.0707608","article-title":"Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells","volume":"153","author":"Condorelli","year":"2008","journal-title":"Br. J. Pharmacol"},{"key":"10.1074\/jbc.M113.472563_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1124\/mol.110.068122","article-title":"The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases. In vitroin silico evidence","volume":"79","author":"Mao","year":"2011","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M113.472563_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jcp.20094","article-title":"Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts","volume":"202","author":"Chen","year":"2005","journal-title":"J. Cell. Physiol"},{"key":"10.1074\/jbc.M113.472563_bib10","doi-asserted-by":"crossref","first-page":"e16795","DOI":"10.1371\/journal.pone.0016795","article-title":"Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M113.472563_bib11","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1200\/JCO.2010.32.1398","article-title":"Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphoma","volume":"29","author":"Kirschbaum","year":"2011","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/jbc.M113.472563_bib12","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2174\/1381612043383980","article-title":"A review of depsipeptide and other histone deacetylase inhibitors in clinical trials","volume":"10","author":"Piekarz","year":"2004","journal-title":"Curr. Pharm. Des"},{"key":"10.1074\/jbc.M113.472563_bib13","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1016\/j.bmc.2008.03.050","article-title":"Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group","volume":"16","author":"Chen","year":"2008","journal-title":"Bioorg. Med. Chem"},{"key":"10.1074\/jbc.M113.472563_bib14","doi-asserted-by":"crossref","first-page":"11355","DOI":"10.1074\/jbc.M707362200","article-title":"Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity","volume":"283","author":"Schuetz","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.472563_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2008.08.015","article-title":"The toxicology of clioquinol","volume":"182","author":"Mao","year":"2008","journal-title":"Toxicol. Lett"},{"key":"10.1074\/jbc.M113.472563_bib16","doi-asserted-by":"crossref","first-page":"R897","DOI":"10.1186\/bcr1322","article-title":"Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells","volume":"7","author":"Daniel","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1074\/jbc.M113.472563_bib17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/leu.2008.232","article-title":"Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma","volume":"23","author":"Mao","year":"2009","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M113.472563_bib18","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1158\/0008-5472.CAN-06-3546","article-title":"Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M113.472563_bib19","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/jnci\/djq457","article-title":"Effect of nitroxoline on angiogenesis and growth of human bladder cancer","volume":"102","author":"Shim","year":"2010","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1074\/jbc.M113.472563_bib20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/jnci\/djq198","article-title":"Effect of noncompetitive proteasome inhibition on bortezomib resistance","volume":"102","author":"Li","year":"2010","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1074\/jbc.M113.472563_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1755-5949.2010.00231.x","article-title":"Clioquinol. Review of its mechanisms of action and clinical uses in neurodegenerative disorders","volume":"18","author":"Bareggi","year":"2012","journal-title":"CNS Neurosci. Ther"},{"key":"10.1074\/jbc.M113.472563_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/BJ20081421","article-title":"Clioquinol targets zinc to lysosomes in human cancer cells","volume":"417","author":"Yu","year":"2009","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M113.472563_bib23","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1016\/j.bmc.2009.08.054","article-title":"Synthesis and pharmacological exploitation of clioquinol-derived copper-binding apoptosis inducers triggering reactive oxygen species generation and MAPK pathway activation","volume":"17","author":"Chen","year":"2009","journal-title":"Bioorg. Med. Chem"},{"key":"10.1074\/jbc.M113.472563_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/156800911794519770","article-title":"Clioquinol. A novel copper-dependent and independent proteasome inhibitor","volume":"11","author":"Schimmer","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1074\/jbc.M113.472563_bib25","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1182\/blood-2008-02-142687","article-title":"Cyproheptadine displays preclinical activity in myeloma and leukemia","volume":"112","author":"Mao","year":"2008","journal-title":"Blood"},{"key":"10.1074\/jbc.M113.472563_bib26","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood-2010-05-284810","article-title":"A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway","volume":"117","author":"Mao","year":"2011","journal-title":"Blood"},{"key":"10.1074\/jbc.M113.472563_bib27","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.str.2004.04.012","article-title":"Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases","volume":"12","author":"Somoza","year":"2004","journal-title":"Structure"},{"key":"10.1074\/jbc.M113.472563_bib28","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem"},{"key":"10.1074\/jbc.M113.472563_bib29","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges. The Resp model","volume":"97","author":"Bayly","year":"1993","journal-title":"J. Phys. Chem"},{"key":"10.1074\/jbc.M113.472563_bib30","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/jcc.10349","article-title":"A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations","volume":"24","author":"Duan","year":"2003","journal-title":"J. Comput. Chem"},{"key":"10.1074\/jbc.M113.472563_bib31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem"},{"key":"10.1074\/jbc.M113.472563_bib32","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2007-05-088666","article-title":"A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin","volume":"110","author":"Mao","year":"2007","journal-title":"Blood"},{"key":"10.1074\/jbc.M113.472563_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2010.02.010","article-title":"Histone deacetylases and epigenetic therapies of hematological malignancies","volume":"62","author":"Mercurio","year":"2010","journal-title":"Pharmacol. Res"},{"key":"10.1074\/jbc.M113.472563_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug. Discov"},{"key":"10.1074\/jbc.M113.472563_bib35","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1038\/sj.onc.1206814","article-title":"Epigenetic targets in hematopoietic malignancies","volume":"22","author":"Claus","year":"2003","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.472563_bib36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00062752-200207000-00010","article-title":"Histone deacetylases as therapeutic targets in hematologic malignancies","volume":"9","author":"Melnick","year":"2002","journal-title":"Curr. Opin. Hematol"},{"key":"10.1074\/jbc.M113.472563_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2559.2008.03109.x","article-title":"Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma","volume":"53","author":"Marquard","year":"2008","journal-title":"Histopathology"},{"key":"10.1074\/jbc.M113.472563_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/1535-7163.MCT-09-0495","article-title":"Selective inhibition of histone deacetylases sensitizes malignant cells to death receptor ligands","volume":"9","author":"Wood","year":"2010","journal-title":"Mol. Cancer Ther"},{"key":"10.1074\/jbc.M113.472563_bib39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1158\/1541-7786.MCR-04-0070","article-title":"Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-\u03baB\/p65 DNA binding","volume":"3","author":"Hu","year":"2005","journal-title":"Mol. Cancer Res"},{"key":"10.1074\/jbc.M113.472563_bib40","doi-asserted-by":"crossref","first-page":"16528","DOI":"10.1074\/jbc.M109929200","article-title":"Ubiquitin\/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest","volume":"277","author":"Hu","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.472563_bib41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00775-009-0594-5","article-title":"Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells","volume":"15","author":"Zhai","year":"2010","journal-title":"J. Biol. Inorg Chem"},{"key":"10.1074\/jbc.M113.472563_bib42","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/AAC.10.2.234","article-title":"Hydroxyquinolines inhibit ribonucleic acid-dependent deoxyribonucleic acid polymerase and inactivate Rous sarcoma virus and herpes simplex virus","volume":"10","author":"Rohde","year":"1976","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1074\/jbc.M113.472563_bib43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.472563_bib44","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1128\/MCB.23.8.2669-2679.2003","article-title":"The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21\/WAF1\/CIP1 gene","volume":"23","author":"Lagger","year":"2003","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M113.472563_bib45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cell.2008.03.025","article-title":"Acetylation is indispensable for p53 activation","volume":"133","author":"Tang","year":"2008","journal-title":"Cell"},{"key":"10.1074\/jbc.M113.472563_bib46","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1073\/pnas.0308762101","article-title":"Acetylation of p53 augments its site-specific DNA binding both in vitroin vivo","volume":"101","author":"Luo","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.472563_bib47","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/jpet.107.130377","article-title":"Clioquinol promotes cancer cell toxicity through tumor necrosis factor \u03b1 release from macrophages","volume":"324","author":"Du","year":"2008","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.M113.472563_bib48","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood-2009-07-235663","article-title":"Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma","volume":"116","author":"Kikuchi","year":"2010","journal-title":"Blood"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192581954399X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192581954399X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.472563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T13:52:02Z","timestamp":1616766722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192581954399X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":48,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S002192581954399X"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.472563","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}